Smeal Benjamin C.
SEC insider (Form 3/4/5 filer). CIK 0001748561. Director at Evoke Pharma Inc (EVOK). 4 reported Form 4/5 transactions since Sep 2024; latest on Dec 17, 2025. Located in SOLANA BEACH, CA.
Companies Smeal Benjamin C. has filed insider reports for
- Evoke Pharma Inc (EVOK): Director
Smeal Benjamin C.
CIK: 0001748561
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EVOK
Evoke Pharma Inc
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Dec 17, 2025EVOK
Evoke Pharma Inc
DispositionDirectStock Option (Right to Buy)
5.8K shares- - Dec 17, 2025EVOK
Evoke Pharma Inc
DispositionDirectStock Option (Right to Buy)
1.1K shares- - May 21, 2025EVOK
Evoke Pharma Inc
AwardDirectStock Option (Right to Buy)
1.1K shares- - Oct 18, 2024EVOK
Evoke Pharma Inc
AwardDirectStock Option (Right to Buy)
5.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 17, 2025 | EVOK Evoke Pharma Inc | Disposition Stock Option (Right to Buy) | 5,833 | - | - | Direct |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | Disposition Stock Option (Right to Buy) | 1,125 | - | - | Direct |
| May 21, 2025 | EVOK Evoke Pharma Inc | Award Stock Option (Right to Buy) | 1,125 | - | - | Direct |
| Oct 18, 2024 | EVOK Evoke Pharma Inc | Award Stock Option (Right to Buy) | 5,833 | - | - | Direct |
1-4 of 4 transactions